OKLAHOMA CITY (AP) - Researchers at the University of Oklahoma Health Sciences Center say an anti-cholesterol drug is showing promise in helping treat hepatitis C. Gastroenterologist Dr. Ted Bader at the Oklahoma City VA Medical Center used the drug fluvastatin to treat veterans who weren't responding to standard treatment for hepatitis C. Bader found the drug reduced the level of the virus six-fold in the blood of two out of every three patients tested. And he says half the patients showed a reduction of hepatitis C in their blood within a month. Bader is now looking for people to take part in phase two of the testing. His findings appear today in the American Journal of Gastroenterology.